IP Library Assignment 054558/0437
Patent Assignment
Reel/Frame 054558/0437

Change of Name

Recorded: 2020-12-01 Pages: 4
Assignor
MENLO THERAPEUTICS INC.
Executed: 2020-09-04
Assignee
VYNE THERAPEUTICS INC.
520 U.S. HIGHWAY 22, SUITE 204, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties (14)
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,198,898 →
Application: 14/312,942 →
Publication: US 2015/0057255
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Patent: 9,486,439 →
Application: 14/899,255 →
Publication: US 2016/0143882
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,381,188 →
Application: 14/922,684 →
Publication: US 2016/0038462
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,474,741 →
Application: 15/175,358 →
Publication: US 2016/0279100
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Patent: 9,737,507 →
Application: 15/269,792 →
Publication: US 2017/0065557
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,737,508 →
Application: 15/271,103 →
Publication: US 2017/0065558
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Patent: 9,974,769 →
Application: 15/626,001 →
Publication: US 2017/0348282
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,968,588 →
Application: 15/626,002 →
Publication: US 2017/0348283
Use of Nk-1 Receptor Antagonists in Pruritus
Application: 15/949,843 →
Publication: US 2018/0325866
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Application: 15/956,102 →
Publication: US 2018/0325867
Use of Neurokinin-1 Antagonists to Treat a Variety of Pruritic Conditions
Application: 16/312,900 →
Publication: US 2019/0216779
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Application: 16/364,075 →
Publication: US 2020/0054603
Use of Nk-1 Receptor Antagonists in Pruritus
Application: 16/364,078 →
Publication: US 2020/0054604
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Application: 16/806,752 →
Publication: US 2020/0306224
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 22, 2014
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 033594/0099 →
Change of Name Jul 6, 2016
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 039197/0765 →
Assignment of Assignor's Interest May 5, 2017
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 042259/0057 →
Change of Name May 5, 2017
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 042418/0481 →
Assignment of Assignor's Interest May 5, 2017
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 042258/0517 →
Assignment of Assignor's Interest Sep 11, 2018
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 046842/0175 →
Assignment of Assignor's Interest Sep 11, 2018
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 046842/0424 →
Assignment of Assignor's Interest Sep 11, 2018
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 046842/0458 →
Change of Name Sep 11, 2018
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 047051/0187 →
Assignment of Assignor's Interest Jan 7, 2019
From: BASTA, STEVEN; JOING, MARK; ZHANG, XIAOMING; KWON, PAUL
To: MENLO THERAPEUTICS INC.
Reel/Frame 047922/0110 →
Change of Name May 3, 2019
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 049085/0793 →
Assignment of Assignor's Interest May 3, 2019
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 049077/0009 →
Assignment of Assignor's Interest May 3, 2019
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 049077/0021 →
Assignment of Assignor's Interest May 3, 2019
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 049077/0115 →
Patent Security Agreement Mar 9, 2020
From: MENLO THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 052130/0980 →
Change of Name Jul 31, 2020
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 053375/0924 →
Assignment of Assignor's Interest Jul 31, 2020
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 053369/0354 →
Release of Security Interest Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057531/0986 →